Nothing Special   »   [go: up one dir, main page]

NO972846D0 - Fremgangsmåte for fremsilling av et polyoksyalkylenderivat substituert med suksinimidylgruppe - Google Patents

Fremgangsmåte for fremsilling av et polyoksyalkylenderivat substituert med suksinimidylgruppe

Info

Publication number
NO972846D0
NO972846D0 NO972846A NO972846A NO972846D0 NO 972846 D0 NO972846 D0 NO 972846D0 NO 972846 A NO972846 A NO 972846A NO 972846 A NO972846 A NO 972846A NO 972846 D0 NO972846 D0 NO 972846D0
Authority
NO
Norway
Prior art keywords
preparation
derivative substituted
polyoxyalkylene derivative
succinimidyl group
succinimidyl
Prior art date
Application number
NO972846A
Other languages
English (en)
Other versions
NO972846L (no
NO312634B1 (no
Inventor
Kouzoh Sanchika
Tohru Yasukohchi
Kei-Ichi Maruyama
Syunsuke Ohhashi
Original Assignee
Nof Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nof Corp filed Critical Nof Corp
Publication of NO972846D0 publication Critical patent/NO972846D0/no
Publication of NO972846L publication Critical patent/NO972846L/no
Publication of NO312634B1 publication Critical patent/NO312634B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33331—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
    • C08G65/33337—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrrole Compounds (AREA)
  • Polyethers (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19972846A 1996-11-05 1997-06-19 Fremgangsmåte for fremsilling av et polyoksyalkylenderivat som er substituert med suksinimidylgruppe NO312634B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP08308785A JP3092531B2 (ja) 1996-11-05 1996-11-05 コハク酸イミジル基置換ポリオキシアルキレン誘導体の製造方法

Publications (3)

Publication Number Publication Date
NO972846D0 true NO972846D0 (no) 1997-06-19
NO972846L NO972846L (no) 1998-05-06
NO312634B1 NO312634B1 (no) 2002-06-10

Family

ID=17985283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972846A NO312634B1 (no) 1996-11-05 1997-06-19 Fremgangsmåte for fremsilling av et polyoksyalkylenderivat som er substituert med suksinimidylgruppe

Country Status (5)

Country Link
US (1) US5767284A (no)
EP (1) EP0839849B1 (no)
JP (1) JP3092531B2 (no)
DE (1) DE69703780T2 (no)
NO (1) NO312634B1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362254B2 (en) 1998-03-12 2002-03-26 Shearwater Corporation Poly(ethylene glycol) derivatives with proximal reactive groups
ATE471956T1 (de) * 2001-01-30 2010-07-15 Kyowa Hakko Kirin Co Ltd Verzweigte polyalkylenglykole
JP4123856B2 (ja) 2001-07-31 2008-07-23 日油株式会社 生体関連物質の修飾剤およびポリオキシアルキレン誘導体の製造方法
DE60321825D1 (de) 2002-12-31 2008-08-07 Nektar Therapeutics Al Corp Maleinsäureamid polymerderivate und ihre biokonjugate
US7482376B2 (en) * 2003-07-03 2009-01-27 3-Dimensional Pharmaceuticals, Inc. Conjugated complement cascade inhibitors
AU2005278903A1 (en) * 2004-08-31 2006-03-09 Pharmacia & Upjohn Company Llc Glycerol branched polyethylene glycol human growth hormone conjugates, process for their preparation, and methods of use thereof
US8383161B2 (en) 2009-12-15 2013-02-26 Incept, Llc Radioopaque covalently crosslinked hydrogel particle implants
KR101692706B1 (ko) * 2009-12-23 2017-01-04 홍콩 메이리셩 플로링 컴퍼니 리미티드 간편 설치용 바닥판재
WO2011143274A1 (en) 2010-05-10 2011-11-17 Perseid Therapeutics Polypeptide inhibitors of vla4

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57206622A (en) * 1981-06-10 1982-12-18 Ajinomoto Co Inc Blood substitute
WO1992000748A1 (en) * 1990-07-06 1992-01-23 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
JP2656717B2 (ja) * 1993-08-18 1997-09-24 住金化工株式会社 Ｎ−スクシンイミジル−２−キノリンカルボキシレートの製造方法
US5484945A (en) * 1993-08-24 1996-01-16 Mitsui Toatsu Chemicals, Inc. Preparation process of polysuccinimide
US5730990A (en) * 1994-06-24 1998-03-24 Enzon, Inc. Non-antigenic amine derived polymers and polymer conjugates

Also Published As

Publication number Publication date
JPH10139877A (ja) 1998-05-26
JP3092531B2 (ja) 2000-09-25
NO972846L (no) 1998-05-06
DE69703780T2 (de) 2001-04-19
US5767284A (en) 1998-06-16
EP0839849A1 (en) 1998-05-06
DE69703780D1 (de) 2001-02-01
NO312634B1 (no) 2002-06-10
EP0839849B1 (en) 2000-12-27

Similar Documents

Publication Publication Date Title
FI104170B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi
DK0797542T3 (da) Fremgangsmåde til fremstilling af aluminosilikatderivater
FI971812A0 (fi) Menetelmä yhdistekokoelman valmistamiseksi
MA23850A1 (fr) Procede de preparation de compositions vaccinantes
MA23918A1 (fr) Procede de preparation de compositions vaccinantes
NO970939D0 (no) Fremgangsmåte ved fremstilling av paroksetinhydrokloridanhydrat
MA23814A1 (fr) Procede de preparation de compositions vaccinantes
NO972845L (no) FremgangsmÕte for fremstilling av et polyoksyalkylenderivat substituert med suksinimidylgruppe
NO970293D0 (no) Substituerte camptotecinderivater og fremgangsmåte for dens fremstilling
NO931346L (no) Fremgangsmaate for fremstilling av et bifenylderivat
FI940769A (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
NO972846D0 (no) Fremgangsmåte for fremsilling av et polyoksyalkylenderivat substituert med suksinimidylgruppe
NO965113L (no) Fremgangsmåte ved fremstilling av et steroid-ketalderivat
NO982237D0 (no) Ny fremgangsmÕte for fremstilling av fenylimidazolidinderivater
FI95036B (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
ID18898A (id) Proses untuk piridin tersubstitusi
NO20024060L (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
NO943652D0 (no) Fremgangsmåte for fremstilling av 3-aminopyridiner fra 3-nitropyridiner
IL126105A0 (en) Novel furan diarylmethylidene derivatives method for their preparation and therapeutical uses thereof
PT99268A (pt) Processo para a preparacao de derivados da 8-cloroquinolona
BG96711A (bg) Метод за получаване на алкенилни производни
GR900100364A (en) Method for preparating pharmaceutical compositions
NO179909C (no) Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater
DK0789700T3 (da) Forbedret fremgangsmåde til fremstilling af et D-(+)-biotin-mellemprodukt

Legal Events

Date Code Title Description
MK1K Patent expired